In non-alcoholic fatty liver disease (NAFLD) patients and obese mice, occupancy of SHP and DNMT3A and DNA methylation at lipogenic genes are low, with elevated gene expression. Here, DNMT3A is linked to metabolic dysfunction-associated steatotic liver disease.